#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4338992	Functional	Antiviral activity in HBV infected in human HepG2.2.15 cells assessed as reduction in viral replication incubated for 5 days by qPCR analysis	Hepatitis B virus	2	ALA4334551	organism-based format	Scientific Literature
2.	ALA4338994	Functional	Antiviral activity in HBV infected in human HepAD38 cells assessed as reduction in viral replication incubated for 65 hrs by RT-PCR analysis	Hepatitis B virus	12	ALA4334551	organism-based format	Scientific Literature
3.	ALA4338995	ADME	Cytotoxicity against human HepAD38 cells assessed as reduction in cell viability incubated for 65 hrs by EZ-Cytox cell viability assay	Homo sapiens	12	ALA4334551	cell-based format	Scientific Literature
4.	ALA4434278	ADME	Half life in human at 200 mg	Homo sapiens	1	ALA4433248	assay format	Scientific Literature
5.	ALA4434279	Functional	Antiviral activity against Hepatitis B virus infected in naive HBeAg positive patients assessed as log10 reduction in HBV DNA at 600 mg bid	Hepatitis B virus	1	ALA4433248	organism-based format	Scientific Literature
6.	ALA4434280	Binding	Binding affinity to capsid protein in Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBV DNA replication incubated for 3 days followed by replacement of fresh medium containing compound and measured after 3 days by chemiluminescent assay	Hepatitis B virus	21	ALA4433248	cell-based format	Scientific Literature
7.	ALA4434281	ADME	Cytotoxicity against human HepG2.2.15 cells assessed as reduction in cell viability incubated for 3 days followed by replacement of fresh medium containing compound and measured after 3 days by cell titer glo-based luminescence assay	Homo sapiens	21	ALA4433248	cell-based format	Scientific Literature
8.	ALA4434296	Functional	Ratio of EC50 for antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells in presence of 40% normal human serum to EC50 for antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells in absence of 40% normal human serum	Hepatitis B virus	3	ALA4433248	organism-based format	Scientific Literature
9.	ALA4434297	Physicochemical	Lipophilicity, log P of the compound		3	ALA4433248	small-molecule physicochemical format	Scientific Literature
10.	ALA4434305	ADME	Ratio of drug concentration in liver to plasma of CD1 mouse	Mus musculus	3	ALA4433248	cell-free format	Scientific Literature
11.	ALA4620093	Functional	Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells by solid phase radioimmunoassay	Hepatitis B virus	8	ALA4619714	organism-based format	Scientific Literature
12.	ALA4620094	ADME	Cytotoxicity against human HepG2.2.15 cells	Homo sapiens	8	ALA4619714	cell-based format	Scientific Literature
13.	ALA4620095	Toxicity	Selectivity index, ratio of CC50 for human HepG2.2.15 cells to IC50 for Hepatitis B virus		8	ALA4619714	assay format	Scientific Literature
14.	ALA4620096	Physicochemical	Solubility of compound at pH 2 by HPLC-UV analysis		1	ALA4619714	small-molecule physicochemical format	Scientific Literature
15.	ALA4620097	ADME	Half life in ICR mouse at 50 mg/kg, po	Mus musculus	2	ALA4619714	organism-based format	Scientific Literature
16.	ALA4620098	ADME	Tmax in ICR mouse at 50 mg/kg, po	Mus musculus	2	ALA4619714	organism-based format	Scientific Literature
17.	ALA4620099	ADME	Cmax in ICR mouse at 50 mg/kg, po	Mus musculus	2	ALA4619714	organism-based format	Scientific Literature
18.	ALA4620100	ADME	AUC (0 to t) in ICR mouse at 50 mg/kg, po	Mus musculus	2	ALA4619714	organism-based format	Scientific Literature
19.	ALA4620101	ADME	MRT in ICR mouse at 50 mg/kg, po	Mus musculus	2	ALA4619714	organism-based format	Scientific Literature
20.	ALA4620110	Functional	Antiviral activity against Hepatitis B virus infected in C57BL/6 mouse assessed as reduction in viral DNA at 0.93 mmol/kg, po administered bid and measured on day 2 by qRT-PCR analysis	Hepatitis B virus	2	ALA4619714	organism-based format	Scientific Literature